K252126 is an FDA 510(k) clearance for the MitraPatch Mitral Valve Repair System. This device is classified as a Nonabsorbable Expanded Polytetrafluoroethylene Surgical Suture For Chordae Tendinae Repair Or Replacement (Class II - Special Controls, product code PAW).
Submitted by Chawla Heart Technologies, LLC (Bloomfield, US). The FDA issued a Cleared decision on December 4, 2025, 150 days after receiving the submission on July 7, 2025.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.3470. To Repair Or Replace Chordae Tendinae..